COVID-19TRIPS 2021: A Changed IP Landscape for Defeating COVID-19January 28, 2021 New Year’s Day 2021 was a nail-biter. Hope from the rollout of 95% effective COVID-19…Doris Estelle Long TRIPS The India South Africa Proposal: Strengths & WeaknessesOctober 29, 2020 On October 2, 2020, India and South Africa jointly tabled a proposal titled Waiver From…Srividhya Ragavan PatentsTRIPS Patents and Trade: Opportunities and Challenges in the Global Healthcare Market September 11, 2020 The present global COVID-19 pandemic has highlighted in stark terms some of the fault lines…Doris Estelle Long Data ExclusivitiesTRIPS Data Exclusivity and Trips Flexibilities: Going Back to the BasicsAugust 18, 2020 The COVID-19 pandemic has provided enough food for thought to reconsider public healthcare issues and…Sonal Singh Patent PoolsPatentsTRIPSVoluntary Licenses Patent Pools: An Attempt to Reinforce the Status Quo and Private OrderingJuly 20, 2020 The experience of the HIV/AIDS epidemic wherein patents hindered access to affordable medicines raises serious…Shirin Syed TRIPSTRIPS Flexibilities Beyond Data Exclusivities: Redefining Access to “Necessary Data” in the Era of COVID-19July 20, 2020 We are in the Age of Data. As fights grow to secure greater open access…Doris Estelle Long PatentsTRIPS IP barriers in tackling COVID 19: Anything in TRIPS to help out?July 1, 2020 The recent World Health Organization Assembly (WHA) resolution calls for timely and equitable access to…Shirin Syed COVID-19ExhaustionPatentsTRIPS TRIPS, COVID-19 and the Right to Repair and Produce Needed Medical Products in Emergencies (Part 2 of 2)June 11, 2020 This is Part 2 of a two-part article. In response to the COVID-19 pandemic, companies,…Joshua D. Sarnoff COVID-19Experimental UsePatentsTRIPS Making Sure Patent Rights Create Space for R&D against the Coronavirus (COVID-19)May 18, 2020 Welcome to our first installment of TradeRX Reports. We first began discussing a blog dedicated…Doris Estelle Long COVID-19TRIPS COVID-19 Should Change the U.S. Posture on Global Access to MedicationMay 18, 2020 The U.S. has long deferred to pharmaceutical companies on questions of pricing and availability of…Michael PalmedoSrividhya Ragavan Previous 1 2 3 Next Search Search Blog Front Page CategoriesCategories Select Category ALL (1) Conferences and Papers (1) COVID-19 (26) Data Exclusivities (5) Deceptive Claims (1) Exhaustion (2) Experimental Use (1) IPAB (1) Patent Pools (2) Patents (18) Right to Health (5) TAMU (1) Trade Policy (6) TRIPS (24) TRIPS Flexibilities (6) Vaccines (6) Voluntary Licenses (1) Archives Archives Select Month July 2022 June 2022 March 2022 December 2021 November 2021 October 2021 September 2021 August 2021 July 2021 May 2021 February 2021 January 2021 December 2020 October 2020 September 2020 August 2020 July 2020 June 2020 May 2020 Regular Contributors Doris Estelle Long (13) Srividhya Ragavan (12) Shirin Syed (4) Michael Palmedo (3) Jonathan Kimball (1) Sonal Singh (1) All Authors RECENT POSTS Call For Papers: The Eighth Annual IP Mosaic Conference Working with the Ministerial Decision on TRIPS Ministerial Decision: “TRIPped” the Waiver? Intellectual Property Law and Access to Medicines Named One of the Best New Intellectual Property Books by BookAuthority Omicron: Requires TRIPS Waiver Vaccine
TRIPS The India South Africa Proposal: Strengths & WeaknessesOctober 29, 2020 On October 2, 2020, India and South Africa jointly tabled a proposal titled Waiver From…Srividhya Ragavan PatentsTRIPS Patents and Trade: Opportunities and Challenges in the Global Healthcare Market September 11, 2020 The present global COVID-19 pandemic has highlighted in stark terms some of the fault lines…Doris Estelle Long Data ExclusivitiesTRIPS Data Exclusivity and Trips Flexibilities: Going Back to the BasicsAugust 18, 2020 The COVID-19 pandemic has provided enough food for thought to reconsider public healthcare issues and…Sonal Singh Patent PoolsPatentsTRIPSVoluntary Licenses Patent Pools: An Attempt to Reinforce the Status Quo and Private OrderingJuly 20, 2020 The experience of the HIV/AIDS epidemic wherein patents hindered access to affordable medicines raises serious…Shirin Syed TRIPSTRIPS Flexibilities Beyond Data Exclusivities: Redefining Access to “Necessary Data” in the Era of COVID-19July 20, 2020 We are in the Age of Data. As fights grow to secure greater open access…Doris Estelle Long PatentsTRIPS IP barriers in tackling COVID 19: Anything in TRIPS to help out?July 1, 2020 The recent World Health Organization Assembly (WHA) resolution calls for timely and equitable access to…Shirin Syed COVID-19ExhaustionPatentsTRIPS TRIPS, COVID-19 and the Right to Repair and Produce Needed Medical Products in Emergencies (Part 2 of 2)June 11, 2020 This is Part 2 of a two-part article. In response to the COVID-19 pandemic, companies,…Joshua D. Sarnoff COVID-19Experimental UsePatentsTRIPS Making Sure Patent Rights Create Space for R&D against the Coronavirus (COVID-19)May 18, 2020 Welcome to our first installment of TradeRX Reports. We first began discussing a blog dedicated…Doris Estelle Long COVID-19TRIPS COVID-19 Should Change the U.S. Posture on Global Access to MedicationMay 18, 2020 The U.S. has long deferred to pharmaceutical companies on questions of pricing and availability of…Michael PalmedoSrividhya Ragavan Previous 1 2 3 Next Search Search Blog Front Page CategoriesCategories Select Category ALL (1) Conferences and Papers (1) COVID-19 (26) Data Exclusivities (5) Deceptive Claims (1) Exhaustion (2) Experimental Use (1) IPAB (1) Patent Pools (2) Patents (18) Right to Health (5) TAMU (1) Trade Policy (6) TRIPS (24) TRIPS Flexibilities (6) Vaccines (6) Voluntary Licenses (1) Archives Archives Select Month July 2022 June 2022 March 2022 December 2021 November 2021 October 2021 September 2021 August 2021 July 2021 May 2021 February 2021 January 2021 December 2020 October 2020 September 2020 August 2020 July 2020 June 2020 May 2020 Regular Contributors Doris Estelle Long (13) Srividhya Ragavan (12) Shirin Syed (4) Michael Palmedo (3) Jonathan Kimball (1) Sonal Singh (1) All Authors RECENT POSTS Call For Papers: The Eighth Annual IP Mosaic Conference Working with the Ministerial Decision on TRIPS Ministerial Decision: “TRIPped” the Waiver? Intellectual Property Law and Access to Medicines Named One of the Best New Intellectual Property Books by BookAuthority Omicron: Requires TRIPS Waiver Vaccine
PatentsTRIPS Patents and Trade: Opportunities and Challenges in the Global Healthcare Market September 11, 2020 The present global COVID-19 pandemic has highlighted in stark terms some of the fault lines…Doris Estelle Long Data ExclusivitiesTRIPS Data Exclusivity and Trips Flexibilities: Going Back to the BasicsAugust 18, 2020 The COVID-19 pandemic has provided enough food for thought to reconsider public healthcare issues and…Sonal Singh Patent PoolsPatentsTRIPSVoluntary Licenses Patent Pools: An Attempt to Reinforce the Status Quo and Private OrderingJuly 20, 2020 The experience of the HIV/AIDS epidemic wherein patents hindered access to affordable medicines raises serious…Shirin Syed TRIPSTRIPS Flexibilities Beyond Data Exclusivities: Redefining Access to “Necessary Data” in the Era of COVID-19July 20, 2020 We are in the Age of Data. As fights grow to secure greater open access…Doris Estelle Long PatentsTRIPS IP barriers in tackling COVID 19: Anything in TRIPS to help out?July 1, 2020 The recent World Health Organization Assembly (WHA) resolution calls for timely and equitable access to…Shirin Syed COVID-19ExhaustionPatentsTRIPS TRIPS, COVID-19 and the Right to Repair and Produce Needed Medical Products in Emergencies (Part 2 of 2)June 11, 2020 This is Part 2 of a two-part article. In response to the COVID-19 pandemic, companies,…Joshua D. Sarnoff COVID-19Experimental UsePatentsTRIPS Making Sure Patent Rights Create Space for R&D against the Coronavirus (COVID-19)May 18, 2020 Welcome to our first installment of TradeRX Reports. We first began discussing a blog dedicated…Doris Estelle Long COVID-19TRIPS COVID-19 Should Change the U.S. Posture on Global Access to MedicationMay 18, 2020 The U.S. has long deferred to pharmaceutical companies on questions of pricing and availability of…Michael PalmedoSrividhya Ragavan Previous 1 2 3 Next Search Search Blog Front Page CategoriesCategories Select Category ALL (1) Conferences and Papers (1) COVID-19 (26) Data Exclusivities (5) Deceptive Claims (1) Exhaustion (2) Experimental Use (1) IPAB (1) Patent Pools (2) Patents (18) Right to Health (5) TAMU (1) Trade Policy (6) TRIPS (24) TRIPS Flexibilities (6) Vaccines (6) Voluntary Licenses (1) Archives Archives Select Month July 2022 June 2022 March 2022 December 2021 November 2021 October 2021 September 2021 August 2021 July 2021 May 2021 February 2021 January 2021 December 2020 October 2020 September 2020 August 2020 July 2020 June 2020 May 2020 Regular Contributors Doris Estelle Long (13) Srividhya Ragavan (12) Shirin Syed (4) Michael Palmedo (3) Jonathan Kimball (1) Sonal Singh (1) All Authors RECENT POSTS Call For Papers: The Eighth Annual IP Mosaic Conference Working with the Ministerial Decision on TRIPS Ministerial Decision: “TRIPped” the Waiver? Intellectual Property Law and Access to Medicines Named One of the Best New Intellectual Property Books by BookAuthority Omicron: Requires TRIPS Waiver Vaccine
Data ExclusivitiesTRIPS Data Exclusivity and Trips Flexibilities: Going Back to the BasicsAugust 18, 2020 The COVID-19 pandemic has provided enough food for thought to reconsider public healthcare issues and…Sonal Singh Patent PoolsPatentsTRIPSVoluntary Licenses Patent Pools: An Attempt to Reinforce the Status Quo and Private OrderingJuly 20, 2020 The experience of the HIV/AIDS epidemic wherein patents hindered access to affordable medicines raises serious…Shirin Syed TRIPSTRIPS Flexibilities Beyond Data Exclusivities: Redefining Access to “Necessary Data” in the Era of COVID-19July 20, 2020 We are in the Age of Data. As fights grow to secure greater open access…Doris Estelle Long PatentsTRIPS IP barriers in tackling COVID 19: Anything in TRIPS to help out?July 1, 2020 The recent World Health Organization Assembly (WHA) resolution calls for timely and equitable access to…Shirin Syed COVID-19ExhaustionPatentsTRIPS TRIPS, COVID-19 and the Right to Repair and Produce Needed Medical Products in Emergencies (Part 2 of 2)June 11, 2020 This is Part 2 of a two-part article. In response to the COVID-19 pandemic, companies,…Joshua D. Sarnoff COVID-19Experimental UsePatentsTRIPS Making Sure Patent Rights Create Space for R&D against the Coronavirus (COVID-19)May 18, 2020 Welcome to our first installment of TradeRX Reports. We first began discussing a blog dedicated…Doris Estelle Long COVID-19TRIPS COVID-19 Should Change the U.S. Posture on Global Access to MedicationMay 18, 2020 The U.S. has long deferred to pharmaceutical companies on questions of pricing and availability of…Michael PalmedoSrividhya Ragavan Previous 1 2 3 Next Search Search Blog Front Page CategoriesCategories Select Category ALL (1) Conferences and Papers (1) COVID-19 (26) Data Exclusivities (5) Deceptive Claims (1) Exhaustion (2) Experimental Use (1) IPAB (1) Patent Pools (2) Patents (18) Right to Health (5) TAMU (1) Trade Policy (6) TRIPS (24) TRIPS Flexibilities (6) Vaccines (6) Voluntary Licenses (1) Archives Archives Select Month July 2022 June 2022 March 2022 December 2021 November 2021 October 2021 September 2021 August 2021 July 2021 May 2021 February 2021 January 2021 December 2020 October 2020 September 2020 August 2020 July 2020 June 2020 May 2020 Regular Contributors Doris Estelle Long (13) Srividhya Ragavan (12) Shirin Syed (4) Michael Palmedo (3) Jonathan Kimball (1) Sonal Singh (1) All Authors RECENT POSTS Call For Papers: The Eighth Annual IP Mosaic Conference Working with the Ministerial Decision on TRIPS Ministerial Decision: “TRIPped” the Waiver? Intellectual Property Law and Access to Medicines Named One of the Best New Intellectual Property Books by BookAuthority Omicron: Requires TRIPS Waiver Vaccine
Patent PoolsPatentsTRIPSVoluntary Licenses Patent Pools: An Attempt to Reinforce the Status Quo and Private OrderingJuly 20, 2020 The experience of the HIV/AIDS epidemic wherein patents hindered access to affordable medicines raises serious…Shirin Syed TRIPSTRIPS Flexibilities Beyond Data Exclusivities: Redefining Access to “Necessary Data” in the Era of COVID-19July 20, 2020 We are in the Age of Data. As fights grow to secure greater open access…Doris Estelle Long PatentsTRIPS IP barriers in tackling COVID 19: Anything in TRIPS to help out?July 1, 2020 The recent World Health Organization Assembly (WHA) resolution calls for timely and equitable access to…Shirin Syed COVID-19ExhaustionPatentsTRIPS TRIPS, COVID-19 and the Right to Repair and Produce Needed Medical Products in Emergencies (Part 2 of 2)June 11, 2020 This is Part 2 of a two-part article. In response to the COVID-19 pandemic, companies,…Joshua D. Sarnoff COVID-19Experimental UsePatentsTRIPS Making Sure Patent Rights Create Space for R&D against the Coronavirus (COVID-19)May 18, 2020 Welcome to our first installment of TradeRX Reports. We first began discussing a blog dedicated…Doris Estelle Long COVID-19TRIPS COVID-19 Should Change the U.S. Posture on Global Access to MedicationMay 18, 2020 The U.S. has long deferred to pharmaceutical companies on questions of pricing and availability of…Michael PalmedoSrividhya Ragavan Previous 1 2 3 Next Search Search Blog Front Page CategoriesCategories Select Category ALL (1) Conferences and Papers (1) COVID-19 (26) Data Exclusivities (5) Deceptive Claims (1) Exhaustion (2) Experimental Use (1) IPAB (1) Patent Pools (2) Patents (18) Right to Health (5) TAMU (1) Trade Policy (6) TRIPS (24) TRIPS Flexibilities (6) Vaccines (6) Voluntary Licenses (1) Archives Archives Select Month July 2022 June 2022 March 2022 December 2021 November 2021 October 2021 September 2021 August 2021 July 2021 May 2021 February 2021 January 2021 December 2020 October 2020 September 2020 August 2020 July 2020 June 2020 May 2020 Regular Contributors Doris Estelle Long (13) Srividhya Ragavan (12) Shirin Syed (4) Michael Palmedo (3) Jonathan Kimball (1) Sonal Singh (1) All Authors RECENT POSTS Call For Papers: The Eighth Annual IP Mosaic Conference Working with the Ministerial Decision on TRIPS Ministerial Decision: “TRIPped” the Waiver? Intellectual Property Law and Access to Medicines Named One of the Best New Intellectual Property Books by BookAuthority Omicron: Requires TRIPS Waiver Vaccine
TRIPSTRIPS Flexibilities Beyond Data Exclusivities: Redefining Access to “Necessary Data” in the Era of COVID-19July 20, 2020 We are in the Age of Data. As fights grow to secure greater open access…Doris Estelle Long PatentsTRIPS IP barriers in tackling COVID 19: Anything in TRIPS to help out?July 1, 2020 The recent World Health Organization Assembly (WHA) resolution calls for timely and equitable access to…Shirin Syed COVID-19ExhaustionPatentsTRIPS TRIPS, COVID-19 and the Right to Repair and Produce Needed Medical Products in Emergencies (Part 2 of 2)June 11, 2020 This is Part 2 of a two-part article. In response to the COVID-19 pandemic, companies,…Joshua D. Sarnoff COVID-19Experimental UsePatentsTRIPS Making Sure Patent Rights Create Space for R&D against the Coronavirus (COVID-19)May 18, 2020 Welcome to our first installment of TradeRX Reports. We first began discussing a blog dedicated…Doris Estelle Long COVID-19TRIPS COVID-19 Should Change the U.S. Posture on Global Access to MedicationMay 18, 2020 The U.S. has long deferred to pharmaceutical companies on questions of pricing and availability of…Michael PalmedoSrividhya Ragavan Previous 1 2 3 Next Search Search Blog Front Page CategoriesCategories Select Category ALL (1) Conferences and Papers (1) COVID-19 (26) Data Exclusivities (5) Deceptive Claims (1) Exhaustion (2) Experimental Use (1) IPAB (1) Patent Pools (2) Patents (18) Right to Health (5) TAMU (1) Trade Policy (6) TRIPS (24) TRIPS Flexibilities (6) Vaccines (6) Voluntary Licenses (1) Archives Archives Select Month July 2022 June 2022 March 2022 December 2021 November 2021 October 2021 September 2021 August 2021 July 2021 May 2021 February 2021 January 2021 December 2020 October 2020 September 2020 August 2020 July 2020 June 2020 May 2020 Regular Contributors Doris Estelle Long (13) Srividhya Ragavan (12) Shirin Syed (4) Michael Palmedo (3) Jonathan Kimball (1) Sonal Singh (1) All Authors RECENT POSTS Call For Papers: The Eighth Annual IP Mosaic Conference Working with the Ministerial Decision on TRIPS Ministerial Decision: “TRIPped” the Waiver? Intellectual Property Law and Access to Medicines Named One of the Best New Intellectual Property Books by BookAuthority Omicron: Requires TRIPS Waiver Vaccine
PatentsTRIPS IP barriers in tackling COVID 19: Anything in TRIPS to help out?July 1, 2020 The recent World Health Organization Assembly (WHA) resolution calls for timely and equitable access to…Shirin Syed COVID-19ExhaustionPatentsTRIPS TRIPS, COVID-19 and the Right to Repair and Produce Needed Medical Products in Emergencies (Part 2 of 2)June 11, 2020 This is Part 2 of a two-part article. In response to the COVID-19 pandemic, companies,…Joshua D. Sarnoff COVID-19Experimental UsePatentsTRIPS Making Sure Patent Rights Create Space for R&D against the Coronavirus (COVID-19)May 18, 2020 Welcome to our first installment of TradeRX Reports. We first began discussing a blog dedicated…Doris Estelle Long COVID-19TRIPS COVID-19 Should Change the U.S. Posture on Global Access to MedicationMay 18, 2020 The U.S. has long deferred to pharmaceutical companies on questions of pricing and availability of…Michael PalmedoSrividhya Ragavan Previous 1 2 3 Next Search Search Blog Front Page CategoriesCategories Select Category ALL (1) Conferences and Papers (1) COVID-19 (26) Data Exclusivities (5) Deceptive Claims (1) Exhaustion (2) Experimental Use (1) IPAB (1) Patent Pools (2) Patents (18) Right to Health (5) TAMU (1) Trade Policy (6) TRIPS (24) TRIPS Flexibilities (6) Vaccines (6) Voluntary Licenses (1) Archives Archives Select Month July 2022 June 2022 March 2022 December 2021 November 2021 October 2021 September 2021 August 2021 July 2021 May 2021 February 2021 January 2021 December 2020 October 2020 September 2020 August 2020 July 2020 June 2020 May 2020 Regular Contributors Doris Estelle Long (13) Srividhya Ragavan (12) Shirin Syed (4) Michael Palmedo (3) Jonathan Kimball (1) Sonal Singh (1) All Authors RECENT POSTS Call For Papers: The Eighth Annual IP Mosaic Conference Working with the Ministerial Decision on TRIPS Ministerial Decision: “TRIPped” the Waiver? Intellectual Property Law and Access to Medicines Named One of the Best New Intellectual Property Books by BookAuthority Omicron: Requires TRIPS Waiver Vaccine
COVID-19ExhaustionPatentsTRIPS TRIPS, COVID-19 and the Right to Repair and Produce Needed Medical Products in Emergencies (Part 2 of 2)June 11, 2020 This is Part 2 of a two-part article. In response to the COVID-19 pandemic, companies,…Joshua D. Sarnoff COVID-19Experimental UsePatentsTRIPS Making Sure Patent Rights Create Space for R&D against the Coronavirus (COVID-19)May 18, 2020 Welcome to our first installment of TradeRX Reports. We first began discussing a blog dedicated…Doris Estelle Long COVID-19TRIPS COVID-19 Should Change the U.S. Posture on Global Access to MedicationMay 18, 2020 The U.S. has long deferred to pharmaceutical companies on questions of pricing and availability of…Michael PalmedoSrividhya Ragavan Previous 1 2 3 Next Search Search Blog Front Page CategoriesCategories Select Category ALL (1) Conferences and Papers (1) COVID-19 (26) Data Exclusivities (5) Deceptive Claims (1) Exhaustion (2) Experimental Use (1) IPAB (1) Patent Pools (2) Patents (18) Right to Health (5) TAMU (1) Trade Policy (6) TRIPS (24) TRIPS Flexibilities (6) Vaccines (6) Voluntary Licenses (1) Archives Archives Select Month July 2022 June 2022 March 2022 December 2021 November 2021 October 2021 September 2021 August 2021 July 2021 May 2021 February 2021 January 2021 December 2020 October 2020 September 2020 August 2020 July 2020 June 2020 May 2020 Regular Contributors Doris Estelle Long (13) Srividhya Ragavan (12) Shirin Syed (4) Michael Palmedo (3) Jonathan Kimball (1) Sonal Singh (1) All Authors RECENT POSTS Call For Papers: The Eighth Annual IP Mosaic Conference Working with the Ministerial Decision on TRIPS Ministerial Decision: “TRIPped” the Waiver? Intellectual Property Law and Access to Medicines Named One of the Best New Intellectual Property Books by BookAuthority Omicron: Requires TRIPS Waiver Vaccine
COVID-19Experimental UsePatentsTRIPS Making Sure Patent Rights Create Space for R&D against the Coronavirus (COVID-19)May 18, 2020 Welcome to our first installment of TradeRX Reports. We first began discussing a blog dedicated…Doris Estelle Long COVID-19TRIPS COVID-19 Should Change the U.S. Posture on Global Access to MedicationMay 18, 2020 The U.S. has long deferred to pharmaceutical companies on questions of pricing and availability of…Michael PalmedoSrividhya Ragavan Previous 1 2 3 Next Search Search Blog Front Page CategoriesCategories Select Category ALL (1) Conferences and Papers (1) COVID-19 (26) Data Exclusivities (5) Deceptive Claims (1) Exhaustion (2) Experimental Use (1) IPAB (1) Patent Pools (2) Patents (18) Right to Health (5) TAMU (1) Trade Policy (6) TRIPS (24) TRIPS Flexibilities (6) Vaccines (6) Voluntary Licenses (1) Archives Archives Select Month July 2022 June 2022 March 2022 December 2021 November 2021 October 2021 September 2021 August 2021 July 2021 May 2021 February 2021 January 2021 December 2020 October 2020 September 2020 August 2020 July 2020 June 2020 May 2020 Regular Contributors Doris Estelle Long (13) Srividhya Ragavan (12) Shirin Syed (4) Michael Palmedo (3) Jonathan Kimball (1) Sonal Singh (1) All Authors RECENT POSTS Call For Papers: The Eighth Annual IP Mosaic Conference Working with the Ministerial Decision on TRIPS Ministerial Decision: “TRIPped” the Waiver? Intellectual Property Law and Access to Medicines Named One of the Best New Intellectual Property Books by BookAuthority Omicron: Requires TRIPS Waiver Vaccine
COVID-19TRIPS COVID-19 Should Change the U.S. Posture on Global Access to MedicationMay 18, 2020 The U.S. has long deferred to pharmaceutical companies on questions of pricing and availability of…Michael PalmedoSrividhya Ragavan Previous 1 2 3 Next